| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10238-008-0011-3 |
| P698 | PubMed publication ID | 18818983 |
| P2093 | author name string | Peter Racay | |
| Jozef Hatok | |||
| Dusan Dobrota | |||
| Tatiana Matakova | |||
| Dusan Mistuna | |||
| Eva Babusikova | |||
| P2860 | cites work | Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma | Q24791107 |
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines | Q30617388 | ||
| Primary Bioassay of Human Tumor Stem Cells | Q34661809 | ||
| Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity | Q34662056 | ||
| Heterogeneity of drug resistance in human breast and ovarian cancers | Q34663351 | ||
| The use of the MTT assay to study drug resistance in fresh tumour samples. | Q35045559 | ||
| Chemotherapy sensitivity and resistance assays: a systematic review | Q35853779 | ||
| American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays | Q35853783 | ||
| Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements | Q36131745 | ||
| Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology | Q36798681 | ||
| Drug sensitivity assays in leukaemia and lymphoma | Q37927007 | ||
| The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia? | Q40805664 | ||
| Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma | Q43639979 | ||
| Chemosensitivity testing predicts survival in ovarian cancer. | Q43790092 | ||
| In vitro chemosensitivity testing of selected myeloid cells in acute myeloid leukemia | Q44475806 | ||
| Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. | Q44582379 | ||
| Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. | Q50507117 | ||
| Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. | Q50519303 | ||
| Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. | Q50780770 | ||
| In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. | Q50876738 | ||
| Limitations of the fluorescent probe viability assay. | Q50885828 | ||
| Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. | Q50894706 | ||
| Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. | Q52487386 | ||
| Effects of cancer chemotherapeutic agents on dehydrogenase activity of human cancer tissue in vitro. | Q52778905 | ||
| In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia. | Q53514464 | ||
| In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome. | Q54190227 | ||
| Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells | Q54404456 | ||
| Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity. | Q54422163 | ||
| Application of radioactive precursors for the evaluation of sensitivity of cancer cells to anticancer drugs. | Q54481384 | ||
| Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA) | Q67727767 | ||
| Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician | Q68925435 | ||
| Use of in vitro tests in predictive cancer chemotherapy | Q70154643 | ||
| Acid phosphatase: endpoint for in vitro toxicity tests | Q70155179 | ||
| Prospective clinical trial of a human tumor cloning system | Q70244888 | ||
| Cytogenetic abnormalities of small round cell tumours | Q72508506 | ||
| Extreme drug resistance is common after prior exposure to paclitaxel | Q80461768 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2008-09-26 | |
| P1433 | published in | Clinical and Experimental Medicine | Q15753118 |
| P1476 | title | In vitro assays for the evaluation of drug resistance in tumor cells | |
| P478 | volume | 9 |
| Q37131478 | A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay. |
| Q35376965 | A novel 96well-formatted micro-gap plate enabling drug response profiling on primary tumour samples |
| Q28548303 | Aberrant Apoptotic Response of Colorectal Cancer Cells to Novel Nucleoside Analogues |
| Q40285183 | Alcohol Marketing on Twitter and Instagram: Evidence of Directly Advertising to Youth/Adolescents. |
| Q38795822 | Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay |
| Q89786081 | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
| Q42255764 | Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers. |
| Q58126050 | Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2 |
| Q53703877 | Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in vitro resistance. |
| Q42017900 | Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry |
| Q35136127 | Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells |
| Q36392155 | Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment |
| Q50047916 | Experimental study on the neurotoxic effect of β-amyloid on the cytoskeleton of PC12 cells |
| Q36157472 | Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2. |
| Q37197458 | Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer |
| Q21133613 | Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig model |
| Q38760363 | Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells |
| Q36248902 | Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment |
| Q38716153 | Multinucleated Giant Cancer Cells Produced in Response to Ionizing Radiation Retain Viability and Replicate Their Genome |
| Q35024682 | Prediction of individual response to anticancer therapy: historical and future perspectives |
| Q39387568 | Reaction of metal-binding ligands with the zinc proteome: zinc sensors and N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine |
| Q35162306 | TSQ (6-methoxy-8-p-toluenesulfonamido-quinoline), a common fluorescent sensor for cellular zinc, images zinc proteins |
| Q26749064 | The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival? |
| Q43122986 | The effect of primary cancer cell culture models on the results of drug chemosensitivity assays: the application of perfusion microbioreactor system as cell culture vessel |
Search more.